Empagliflozin as add-on to pioglitazone with or without metformin in patients with Type 2 diabetes

被引：0
|
作者：
Kovacs, C. S. [1 ]
Seshiah, V. [2 ]
Merker, L. [3 ]
Christiansen, A. Vedel [4 ]
Roux, F. [5 ]
Salsali, A. [6 ]
Kim, G. [6 ]
Stella, P. [6 ]
Woerle, H. J. [6 ]
Broedl, U. C. [6 ]
机构：
[1] Mem Univ Newfoundland, Hlth Sci Ctr, St John, NF A1C 5S7, Canada
[2] Diabet Care & Res Inst, Chennai, Tamil Nadu, India
[3] Diabet & Nierenzentrum, Dormagen, Germany
[4] Boehringer Ingelheim Danmark AS, Copenhagen, Denmark
[5] Boehringer Ingelheim France, Reims, France
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
来源：
DIABETIC MEDICINE | 2015年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P190
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [21] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    DIABETES, 2013, 62 : A282 - A282
  • [22] Can add-on pioglitazone prevent recurrent stroke in patients with type 2 diabetes?
    Irene Katzan
    Nature Clinical Practice Neurology, 2007, 3 : 486 - 487
  • [23] Can add-on pioglitazone prevent recurrent stroke in patients with type 2 diabetes?
    Katzan, Irene
    NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (09): : 486 - 487
  • [24] Effect of empagliflozin compared with glimepiride as add-on to metformin for 2 years on the amount and distribution of body fat in patients with type 2 diabetes
    Kim, G.
    Ridderstrale, M.
    Andersen, K. R.
    Zeller, C.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2014, 57 : S330 - S331
  • [25] Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis
    Xiaoyan Zhong
    Dan Lai
    Yun Ye
    Xuping Yang
    Bin Yu
    Yilan Huang
    European Journal of Clinical Pharmacology, 2016, 72 : 655 - 663
  • [26] Type 2 diabetes: which drug as add-on to metformin?
    Madsbad, Sten
    LANCET, 2012, 379 (9833): : 2222 - 2223
  • [27] Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis
    Zhong, Xiaoyan
    Lai, Dan
    Ye, Yun
    Yang, Xuping
    Yu, Bin
    Huang, Yilan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (06) : 655 - 663
  • [28] Pioglitazone or Sulfonylureas as Add-on Therapy to Metformin
    Pavlicek, V.
    DIABETOLOGE, 2018, 14 (02): : 101 - 103
  • [29] Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metformin
    Blevins, Thomas
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 789 - 793
  • [30] Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus
    Talebi, Seyed Saman
    Rezaie, Shabnam
    Hajmiri, Minoo Sadat
    Zamanirafe, Maryam
    Ranjbar, Akram
    Moridi, Heresh
    Mirjalili, Mahtabalsadat
    Mehrpooya, Maryam
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 9149 - 9165
12345